0078-0690-61 |
0078-0690 |
HUMAN PRESCRIPTION DRUG |
ARZERRA |
ofatumumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20160201 |
N/A |
BLA |
BLA125326 |
Novartis Pharmaceuticals Corporation |
OFATUMUMAB |
20 mg/mL |
50 mL in 1 VIAL, SINGLE-USE (0078-0690-61) |
0078-0669-13 |
0078-0669 |
HUMAN PRESCRIPTION DRUG |
ARZERRA |
ofatumumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20160201 |
N/A |
BLA |
BLA125326 |
Novartis Pharmaceuticals Corporation |
OFATUMUMAB |
20 mg/mL |
3 VIAL, SINGLE-USE in 1 CARTON (0078-0669-13) / 5 mL in 1 VIAL, SINGLE-USE (0078-0669-61) |
0078-1007-68 |
0078-1007 |
HUMAN PRESCRIPTION DRUG |
KESIMPTA |
ofatumumab |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20200820 |
N/A |
BLA |
BLA125326 |
Novartis Pharmaceuticals Corporation |
OFATUMUMAB |
20 mg/.4mL |
1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS |
0078-1007-98 |
0078-1007 |
HUMAN PRESCRIPTION DRUG |
KESIMPTA |
ofatumumab |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20200820 |
N/A |
BLA |
BLA125326 |
Novartis Pharmaceuticals Corporation |
OFATUMUMAB |
20 mg/.4mL |
1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS |